RESUMO
Mendelian randomization (MR) utilizes genome-wide association study (GWAS) summary data to infer causal relationships between exposures and outcomes, offering a valuable tool for identifying disease risk factors. Multivariable MR (MVMR) estimates the direct effects of multiple exposures on an outcome. This study tackles the issue of highly correlated exposures commonly observed in metabolomic data, a situation where existing MVMR methods often face reduced statistical power due to multicollinearity. We propose a robust extension of the MVMR framework that leverages constrained maximum likelihood (cML) and employs a Bayesian approach for identifying independent clusters of exposure signals. Applying our method to the UK Biobank metabolomic data for the largest Alzheimer disease (AD) cohort through a two-sample MR approach, we identified two independent signal clusters for AD: glutamine and lipids, with posterior inclusion probabilities (PIPs) of 95.0% and 81.5%, respectively. Our findings corroborate the hypothesized roles of glutamate and lipids in AD, providing quantitative support for their potential involvement.
Assuntos
Doença de Alzheimer , Teorema de Bayes , Estudo de Associação Genômica Ampla , Análise da Randomização Mendeliana , Metabolômica , Humanos , Doença de Alzheimer/genética , Metabolômica/métodos , Polimorfismo de Nucleotídeo Único , Glutamina/metabolismo , Glutamina/genética , Lipídeos/sangue , Lipídeos/genéticaRESUMO
MOTIVATION: Microbiome data analysis faces the challenge of sparsity, with many entries recorded as zeros. In differential abundance analysis, the presence of excessive zeros in data violates distributional assumptions and creates ties, leading to an increased risk of type I errors and reduced statistical power. RESULTS: We developed a novel normalization method, called censoring-based analysis of microbiome proportions (CAMP), for microbiome data by treating zeros as censored observations, transforming raw read counts into tie-free time-to-event-like data. This enables the use of survival analysis techniques, like the Cox proportional hazards model, for differential abundance analysis. Extensive simulations demonstrate that CAMP achieves proper type I error control and high power. Applying CAMP to a human gut microbiome dataset, we identify 60 new differentially abundant taxa across geographic locations, showcasing its usefulness. CAMP overcomes sparsity challenges, enabling improved statistical analysis and providing valuable insights into microbiome data in various contexts. AVAILABILITY AND IMPLEMENTATION: The R package is available at https://github.com/lapsumchan/CAMP.
Assuntos
Microbioma Gastrointestinal , Microbiota , Humanos , Projetos de Pesquisa , Análise de DadosRESUMO
Metabolites are intermediates or end products of biochemical processes involved in both health and disease. Here, we take advantage of the well-characterized Cooperative Health Research in South Tyrol (CHRIS) study to perform an exome-wide association study (ExWAS) on absolute concentrations of 175 metabolites in 3294 individuals. To increase power, we imputed the identified variants into an additional 2211 genotyped individuals of CHRIS. In the resulting dataset of 5505 individuals, we identified 85 single-variant genetic associations, of which 39 have not been reported previously. Fifteen associations emerged at ten variants with >5-fold enrichment in CHRIS compared to non-Finnish Europeans reported in the gnomAD database. For example, the CHRIS-enriched ETFDH stop gain variant p.Trp286Ter (rs1235904433-hexanoylcarnitine) and the MCCC2 stop lost variant p.Ter564GlnextTer3 (rs751970792-carnitine) have been found in patients with glutaric acidemia type II and 3-methylcrotonylglycinuria, respectively, but the loci have not been associated with the respective metabolites in a genome-wide association study (GWAS) previously. We further identified three gene-trait associations, where multiple rare variants contribute to the signal. These results not only provide further evidence for previously described associations, but also describe novel genes and mechanisms for diseases and disease-related traits.
RESUMO
Few studies have explored the impact of rare variants (minor allele frequency < 1%) on highly heritable plasma metabolites identified in metabolomic screens. The Finnish population provides an ideal opportunity for such explorations, given the multiple bottlenecks and expansions that have shaped its history, and the enrichment for many otherwise rare alleles that has resulted. Here, we report genetic associations for 1391 plasma metabolites in 6136 men from the late-settlement region of Finland. We identify 303 novel association signals, more than one third at variants rare or enriched in Finns. Many of these signals identify genes not previously implicated in metabolite genome-wide association studies and suggest mechanisms for diseases and disease-related traits.